Effect of different vitrification protocols for human ovarian tissue on reactive oxygen species and apoptosis.
D017209:Apoptosis; D053148:Caspase 3 / Q000032:analysis; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000032:analysis; D005026:Ethylene Glycols / Q000032:analysis; D005260:Female; D005362:Ficoll / Q000032:analysis; D005452:Fluoresceins / Q000032:analysis; D005456:Fluorescent Dyes / Q000032:analysis; D006801:Humans; D019188:Organ Preservation Solutions / Q000737:chemistry / Q000494:pharmacology*; D010053:Ovary / Q000737:chemistry / Q000166:cytology / Q000187:drug effects*; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species / Q000032:analysis*; D013395:Sucrose / Q000032:analysis
C110400:2',7'-dichlorodihydrofluorescein diacetate; D003451:Cryoprotective Agents; D005026:Ethylene Glycols; D005452:Fluoresceins; D005456:Fluorescent Dyes; D019188:Organ Preservation Solutions; D017382:Reactive Oxygen Species; D005362:Ficoll; D013395:Sucrose; D053148:Caspase 3